Icecure Medical (Icecure Medical) Inventory-to-Revenue : 1.96 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Icecure Medical's Average Total Inventories for the quarter that ended in Dec. 2023 was $2.46 Mil. Icecure Medical's Revenue for the three months ended in Dec. 2023 was $1.26 Mil. Icecure Medical's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.96.

Icecure Medical's Inventory-to-Revenue for the quarter that ended in Dec. 2023 declined from Sep. 2023 (8.25) to Sep. 2023 (1.96)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Icecure Medical's Days Inventory for the three months ended in Dec. 2023 was 327.29.

Inventory Turnover measures how fast the company turns over its inventory within a year. Icecure Medical's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.28.

Icecure Medical Inventory-to-Revenue Historical Data

The historical data trend for Icecure Medical's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical Inventory-to-Revenue Chart

Icecure Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.41

0.23

0.37

0.78

0.80

Icecure Medical Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventory-to-Revenue	Get a 7-Day Free Trial															2.96	4.07	3.03	8.25	1.96

Competitive Comparison of Icecure Medical's Inventory-to-Revenue

For the Medical Devices subindustry, Icecure Medical's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Icecure Medical's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Icecure Medical's Inventory-to-Revenue falls into.

Icecure Medical Inventory-to-Revenue Calculation

Icecure Medical's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (A: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )
=	( (2.857	+	2.275)	/	2 )	/	3.229
=	2.566					/	3.229
=	0.79

Icecure Medical's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (Q: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Revenue (Q: Dec. 2023 )
=	( (2.646	+	2.275)	/	2 )	/	1.255
=	2.4605					/	1.255
=	1.96

Icecure Medical (NAS:ICCM) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Icecure Medical's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	2.4605	/	0.686	*	365 / 4
	=	327.29

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Icecure Medical's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	0.686	/	2.4605
	=	0.28

Icecure Medical Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Icecure Medical's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Icecure Medical (Icecure Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504

Website

https://www.icecure-medical.com

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.